Greetings,
I do research on the health benefits of solar ultraviolet-B (UVB) irradiance and vitamin D. One of the benefits is the induction of human cathelicidin, LL-37, which has important antimicrobial and antiendotoxin activities. John Cannell et al. proposed that seasonal variations in solar UVB and vitamin D could explain a good deal of the seasonal variation in epidemic influenza:
Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol Infect. 2006 Dec;134(6):1129-40.
Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol J. 2008 Feb 25;5(1):29 [Epub ahead of print]
Support was quickly forthcoming in a post-hoc analysis of a randomized controlled trial:
Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect. 2007 Oct;135(7):1095-6; author reply 1097-8.
Bsaed on this paper, which I found through FluTrackers:
Britten RH. The incidence of epidemic influenza, 1918-19. Pub Health Rep. 1932;47:303-39.
http://statelibrary.dcr.state.nc.us/iss/INFLUENZA/PDFfiles/USPHR47All.pdf
I did an ecological analysis of case fatality rates in 12 cities of the United States. The finding was that summertime solar UVB was strongly inversely correlated with case fatality rates, and wintertime UVB was almost as strongly inversely correlated. Looking further at the literature, I realized that most people who died from A/H1N1 influenza actually died from pneumonia, caused by a bacteria. Thus, it seems that in this case, LL-37 had a more important effect on bacteria than the virus. The W-shaped age distribution of the mortality rates seems to be related to immunity for people born prior to 1890 and the outbreak of the Russian flu. However, the seasonality of pandemic influenza indicates that UVB and vitamin D may still play some role in reducing the risk. I will be submitting this manuscript for publication shortly.
Abstracts of published papers are at www.pubmed.gov.
I do research on the health benefits of solar ultraviolet-B (UVB) irradiance and vitamin D. One of the benefits is the induction of human cathelicidin, LL-37, which has important antimicrobial and antiendotoxin activities. John Cannell et al. proposed that seasonal variations in solar UVB and vitamin D could explain a good deal of the seasonal variation in epidemic influenza:
Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol Infect. 2006 Dec;134(6):1129-40.
Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol J. 2008 Feb 25;5(1):29 [Epub ahead of print]
Support was quickly forthcoming in a post-hoc analysis of a randomized controlled trial:
Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect. 2007 Oct;135(7):1095-6; author reply 1097-8.
Bsaed on this paper, which I found through FluTrackers:
Britten RH. The incidence of epidemic influenza, 1918-19. Pub Health Rep. 1932;47:303-39.
http://statelibrary.dcr.state.nc.us/iss/INFLUENZA/PDFfiles/USPHR47All.pdf
I did an ecological analysis of case fatality rates in 12 cities of the United States. The finding was that summertime solar UVB was strongly inversely correlated with case fatality rates, and wintertime UVB was almost as strongly inversely correlated. Looking further at the literature, I realized that most people who died from A/H1N1 influenza actually died from pneumonia, caused by a bacteria. Thus, it seems that in this case, LL-37 had a more important effect on bacteria than the virus. The W-shaped age distribution of the mortality rates seems to be related to immunity for people born prior to 1890 and the outbreak of the Russian flu. However, the seasonality of pandemic influenza indicates that UVB and vitamin D may still play some role in reducing the risk. I will be submitting this manuscript for publication shortly.
Abstracts of published papers are at www.pubmed.gov.